-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
I-XW-053
Category | Human immunodeficiency Virus (HIV) |
CAS | 5496-35-5 |
Description | I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity. |
Product Information
Synonyms | 4-(4,5-Diphenyl-1H-imidazol-2-yl)benzoic Acid;5496-35-5;I-XW-053;2(4-Carboxyphenyl)-4,5-diphenylimidazole;CHEMBL1619186;4-(4,5-Diphenyl-1H-imidazol-2-yl)-benzoic acid;2(p-Carboxyphenyl)-4,5-diphenylimidazole;Oprea1_066808;Oprea1_074112;SCHEMBL2593317;YSZC1408;DTXSID90203487;BDBM50500832;MFCD00999654;AKOS027327439;NCGC00246119-01;2-(p-Carboxyphenyl)-4,5-diphenylimidazol;HY-103078;CS-0023797;D2816;T71048;EN300-7372905;A870309;Benzoic acid, 4-(4,5-diphenyl-1H-imidazol-2-yl)-;4-(4,5-DIPHENYL-1H-IMIDAZOL-2-YL)BENZOICACID; |
IUPAC Name | 4-(4,5-diphenyl-1H-imidazol-2-yl)benzoic acid |
Molecular Weight | 319.4 |
Molecular Formula | C20H17NO3 |
Canonical SMILES | C1=CC=C(C=C1)/C=C/C=C/C(=O)CC2(C3=CC=CC=C3NC2=O)O |
InChI | InChI=1S/C22H16N2O2/c25-22(26)18-13-11-17(12-14-18)21-23-19(15-7-3-1-4-8-15)20(24-21)16-9-5-2-6-10-16/h1-14H,(H,23,24)(H,25,26) |
InChIKey | BCXPNUSETAZHEQ-UHFFFAOYSA-N |
Boiling Point | 596.9°C at 760 mmHg |
Density | 1.263 g/cm3 |
Appearance | Solid |